ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,187, issued on Oct. 20, was assigned to CYCURIA THERAPEUTICS GMBH (Graz, Austria).
"Lymphotoxin alpha for use in therapy of myeloid leukemia" was invented by Philipp J. Jost (Graz, Austria) and Ulrike Hockendorf (Munich).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a polypeptide for use in the treatment of myeloid diseases or myeloid neoplasms, a pharmaceutical composition comprising such a polypeptide for use in the treatment of myeloid diseases or myeloid neoplasms and a kit comprising such a polypeptide for use in the treatment of myeloid diseases or myeloid neoplasms."
The patent was filed on May 15, 2020, unde...